Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 USD | +3.77% | -30.82% | -50.00% |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-50.00% | 556K | |
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |
- Stock Market
- Equities
- BXRX.Q Stock
- News Baudax Bio, Inc.
- Baudax Bio Doses First Cohort of Phase 1 Trial of Clinical-Stage Neuromuscular Blocking Agent BX2000